In addition, FGF stimulation of the FGFR2-overexpressing breast cancer cell line SUM-52PE also enhanced STAT3 tyrosine phosphorylation and transcriptional activity, which was strongly reduced by FGFR2 knockdown or pharmacologic inhibition [40]. The gene discussed is STAT3; the disease is breast cancer.